frangula_purshiana_dc._a._gray
Unterschiede
Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
| Beide Seiten der vorigen RevisionVorhergehende ÜberarbeitungNächste Überarbeitung | Vorhergehende Überarbeitung | ||
| frangula_purshiana_dc._a._gray [2014/11/28 11:30] – andreas | frangula_purshiana_dc._a._gray [2015/06/13 09:38] (aktuell) – Externe Bearbeitung 127.0.0.1 | ||
|---|---|---|---|
| Zeile 9: | Zeile 9: | ||
| The fresh bark contains free anthrones and must be dried for at least 1 year or artificially aged by heat or aeration before therapeutic use. \\ | The fresh bark contains free anthrones and must be dried for at least 1 year or artificially aged by heat or aeration before therapeutic use. \\ | ||
| Contains not less than 8.0% hydroxyanthracene glycosides of which not less than 60% consists of cascarosides, | Contains not less than 8.0% hydroxyanthracene glycosides of which not less than 60% consists of cascarosides, | ||
| - | The active constituents are hydroxyanthracene glycosides (6-9%). Of these, 70-90% are C-10 glycosides, with the 8-O-glycosides, | + | The active constituents are hydroxyanthracene glycosides (6-9%). Of these, 70-90% are C-10 glycosides, with the 8 -O-glycosides, |
| [Cortex Rhamni Purshianae, WHO Monographs on Selected Medicinal Plants - Volume 2, 2004] [[http:// | [Cortex Rhamni Purshianae, WHO Monographs on Selected Medicinal Plants - Volume 2, 2004] [[http:// | ||
frangula_purshiana_dc._a._gray.1417174228.txt.gz · Zuletzt geändert: 2014/11/28 11:30 von andreas
